Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Secondary Mitral Valve Regurgitation: Etiology and Assessment |
Zhiyuan Song | the Southwest Hospital of AMU |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Advances in Treatment of Secondary Mitral Valve Regurgitation |
Ming Gong | Beijing Anzhen Hospital, Capital Medical University, China |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Secondary Tricuspid Valve Regurgitation: Etiology and Assessment |
Ligang Fang | |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Advances in Treatment of Secondary Tricuspid Valve Regurgitation |
Wenzhi Pan | Zhongshan Hospital,Fudan University |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
11:00-11:02 | 11:00-11:02 |
Opening
Jianzeng Dong
The First Affiliated Hospital of Zhengzhou University / Beijing Anzhen Hospital, Capital Medical University
|
||
11:02-11:16 | 11:02-11:16 |
Emerging Data in Heart Failure from ESC, Are We Doing Enough to Improve Patients’ Survival and Quality of Life?
Jian Zhang
Fuwai Hospital of the Chinese Academy of Medical Sciences /
Martin Cowie
National Heart & Lung Institute, Imperial College /
Michael Bohm
University of Saarland Cardiology, Angiology and Intensive Care Medicine
|
||
11:16-11:51 | 11:16-11:51 |
Interpretation of Chinese Expert Consensus on Clinical Application of Lvabradine |
Jun Huang | Jiangsu General Hospital |
11:51-12:09 | 11:51-12:09 |
Case sharing & comments-1 |
||
12:09-12:27 | 12:09-12:27 |
Case Sharing & Comments 2 |
||
12:27-12:30 | 12:27-12:30 |
Chairman Summary
Jianzeng Dong
The First Affiliated Hospital of Zhengzhou University / Beijing Anzhen Hospital, Capital Medical University
|
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
12:30-12:45 | 12:30-12:45 |
Diabetic Cardiomyopathy: Fact or Fiction? |
Hongwei Li | Beijing Friendship Hospital, Capital Medical University |
12:45-13:00 | 12:45-13:00 |
New Evidence on SGLT-2 Inhibitors: and Its Implications |
Jing Li | Xuanwu Hospital Capital Medical University |
13:00-13:15 | 13:00-13:15 |
Diabetic Microangiopathy and Heart Failure |
Jing Yu | Lanzhou University Second Hospital |
13:15-13:30 | 13:15-13:30 |
Management of Glucose in Heart Failure: Evidence and Guideline Evolution |
Liwen Li | Guangdong Provincial People's Hospital |
13:30-13:45 | 13:30-13:45 |
Novel Treatment for Patients with Diabetes and Cardiovascular Disease |
Weimin Li | The First Affiliated Hospital of Harbin Medical University |
13:45-14:00 | 13:45-14:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
14:00-14:15 | 14:00-14:15 |
Diuretics |
Qing Zhang | Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China |
14:15-14:30 | 14:15-14:30 |
Application of Intravenous Inotropic Agents |
Ling Bai | The First Affiliated Hospital of Xian Jiaotong University |
14:30-14:45 | 14:30-14:45 |
β-Blocker and Ivabradine |
Jingmin Zhou | Zhongshan Hospital,Fudan University |
14:45-15:00 | 14:45-15:00 |
RAAS Inhibitor and Spironolactone |
Wei Jin | Shanghai Jiaotong University School of Medicine Ruijin Hospital |
15:00-15:15 | 15:00-15:15 |
Research and Prospect of New Targeted Drugs |
Yuhui Zhang | Fuwai Hospital, Chinese Academy of Medical Sciences |
15:15-15:30 | 15:15-15:30 |
Digoxin: the Initial and Long-term Treatment |
Shenghua Zhou |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:15 | 16:00-16:15 |
Application of Precision Treatment in Heart Failure |
Shuyang Zhang | Peking Union Medical College Hospital |
16:15-16:30 | 16:15-16:30 |
Current Status and Solutions of Heart Failure in China |
Jian Zhang | Fuwai Hospital of the Chinese Academy of Medical Sciences |
16:30-16:45 | 16:30-16:45 |
Safety of RAASi for COVID-19 Patients with Heart Failure |
Aiqun Ma | The First Affiliated Hospital of Xian Jiaotong University |
16:45-17:00 | 16:45-17:00 |
Advances in Non-Pharmacy Treatment for Heart Failure |
Tong Zou | |
17:00-17:15 | 17:00-17:15 |
New Progress on Drug Therapy for Heart Failure in 2020 |
Dingli Xu | Southern Medical University Nanfang Hospital |
17:15-17:30 | 17:15-17:30 |
Current Knowledge of Right-Sided Heart Failure |
Dongjie Xu | Jiangsu General Hospital |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
17:30-17:45 | 17:30-17:45 |
Exercise Rehabilitation Therapy for Patients with Heart Failure |
Wei Zhao | Third hospital, Peiking University |
17:45-17:52 | 17:45-17:52 |
Discussion |
||
17:52-18:07 | 17:52-18:07 |
Management of Salt Intake in Heart Failure |
jingyuan mao | |
18:07-18:14 | 18:07-18:14 |
Discussion |
||
18:14-18:29 | 18:14-18:29 |
Characteristics of Cardiopulmonary Exercise Test in Patients with Different Types of Heart Failure |
Lin Che | Tongji Hospital, Tongji University School of medicine |
18:29-18:36 | 18:29-18:36 |
Discussion |
||
18:36-18:51 | 18:36-18:51 |
Nutritional Intervention in Patients with Heart Failure |
Chunli Song | The Second Hospital of Jilin University |
18:51-19:00 | 18:51-19:00 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
19:00-19:15 | 19:00-19:15 |
Burden of Influenza in Cardiovascular Disease |
Xin Du | |
19:15-19:20 | 19:15-19:20 |
Discussion |
||
19:20-19:35 | 19:20-19:35 |
SLE-related Cardiac Disease |
Lu Zhang | China Japan Friendship Hospital |
19:35-19:40 | 19:35-19:40 |
Discussion |
||
19:40-19:55 | 19:40-19:55 |
Cardiac Function Monitoring in Cancer Treatment and Management |
Ying Liu | The First Affiliated Hospital of Dalian Medical University |
19:55-20:00 | 19:55-20:00 |
Discussion |
||
20:00-20:15 | 20:00-20:15 |
Management of Heart Failure during COVID-19 Pandemic |
Yuhua Liao | Union Hospital of Tongji Medical College,Huazhong University of Science and Technology |
20:15-20:20 | 20:15-20:20 |
Discussion |
||
20:40-20:55 | 20:40-20:55 |
Is Heart Failure with Severe Infection the Takotsubo Cardiomyopathy? |
Yushi Wang | The First Hospital of Jilin University |
20:55-21:00 | 20:55-21:00 |
Discussion |